Cargando…
Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study
SIMPLE SUMMARY: Childhood cancer patients receiving treatment containing alkylating agents are at risk of infertility, yet inter-individual variability in treatment-related ovarian damage is observed. Alkylating agents are metabolized by cytochrome P450 (CYP450) enzymes and polymorphisms in these CY...
Ejemplares similares
-
Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol
por: van der Kooi, Anne-Lotte L. F., et al.
Publicado: (2018) -
Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE)
por: van den Berg, Marleen, et al.
Publicado: (2018) -
Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset
por: Langer, Thorsten, et al.
Publicado: (2020) -
Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study
por: Clemens, Eva, et al.
Publicado: (2019) -
Health-Related Quality of Life in European Childhood Cancer Survivors: Protocol for a Study Within PanCareLIFE
por: Calaminus, Gabriele, et al.
Publicado: (2021)